Paul Cipriano, MD
Vascular & Interventional Radiology · San Jose, CANPI 1669486700
Payments from drug & device makers
Across 36 payments — averaging $73.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$1K
- Inari Medical, Inc.$649
- Stryker$161
- Penumbra, Inc.$118
- Cordis US CORP.$114
- Boston Scientific$105
- plus $317 from 10 others
What the payments were for
- Food & beverage$1,74666%
- Education$90034%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 5 | $1,182 |
| Inari Medical, Inc. | 9 | $649 |
| Stryker | 1 | $161 |
| Penumbra, Inc. | 2 | $118 |
| Cordis US CORP. | 4 | $114 |
| Boston Scientific | 2 | $105 |
| Medtronic | 2 | $66 |
| Novo Nordisk | 2 | $57 |
| Almatica Pharma LLC | 2 | $55 |
| Bard Peripheral Vascular, Inc. | 1 | $28 |
| BD | 1 | $23 |
| Cardiovascular Systems Inc. | 1 | $19 |
| Sirtex Medical Inc | 1 | $19 |
| Asahi Intecc USA, Inc. | 1 | $18 |
| Surmodics, Inc. | 1 | $17 |
| Portola Pharmaceuticals, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,646 in reported general payments places this provider in the 45th percentile of 504 vascular & interventional radiology providers in California.
See all vascular & interventional radiology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular & interventional radiology in San Jose
- Nicholas FidelmanSan Francisco$6.1M
- Mahmood RazaviOrange$3.1M
- Joey EnglishSan Francisco$2.1M
- Sean TuttonSan Diego$1.9M
- Keith TerasakiLos Angeles$1.7M
- Edward LeeLos Angeles$1.7M
- Bart DolmatchMountain View$1.7M
- Siddharth PadiaLos Angeles$1.6M
- Kevin BurnsOrange$1.5M
- Alexander MisonoNewport Beach$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.